wearables for insurance - swiss re › dam › jcr:1ba30f72-04c4-4cdb-936a...restricted - do not...

Restricted - do not distribute beyond defined distribution list or make copies

Wearables for Insurance

Restricted - do not distribute beyond defined distribution list or make copies

Advances in Technology will Change the Future Insurance Business Models

Mobile first preference from

consumers -(Distribution)

More natural interaction with

computers - (Digital Advisors)

Increase of data on people and objects -

(IOT, Telematics)

Common and secure use of data -(BlockchainTechnology)

Ability to recognise patterns in data -

(Artificial Intelligence,

Predictive Analytics)

Restricted - do not distribute beyond defined distribution list or make copies

The Wearable Landscape

https://www.capgemini.com/sites/default/files/resource/image/wearable_devices_ig.jpg

Restricted - do not distribute beyond defined distribution list or make copies

The Wearable Landscape

Restricted - do not distribute beyond defined distribution list or make copies

What's being discussed on Wearables

5

Source: https://lifeinsurancepost.com/wearable-technology-influencing-insurance-industry/

Restricted - do not distribute beyond defined distribution list or make copies

Fitness-Grade

Medical-Grade

We Distinguish Two Basic Types of Wearables

Restricted - do not distribute beyond defined distribution list or make copies

The Cases: Medical Grade Device

A Quiet Sunday

A Working Day

A Day with Challenges

Restricted - do not distribute beyond defined distribution list or make copies

The Cases: Wellness and Engagement Platform

GOQii Ecosystem

Restricted - do not distribute beyond defined distribution list or make copies

The Case Studies: Example

Expert: Vandana Juneja

Restricted - do not distribute beyond defined distribution list or make copies

Disease mgmt.

programs

Prescriptions

Doctor

consultations

Lab results

Health records,

claims

The Cases: Turning Data into Portfolio Insights and Health Actions

Wearables

Restricted - do not distribute beyond defined distribution list or make copies

The Cases: Turning Data into Underwriting Replacement

7 days of wearable data can be used for underwriting?

Restricted - do not distribute beyond defined distribution list or make copies

Apps – Are also a Wearable

Restricted - do not distribute beyond defined distribution list or make copies

Focus on Metabolic Risk and Associated Conditions

Lifestyle Risk Factors, have a positive impact on metabolic factors and associated conditions

Restricted - do not distribute beyond defined distribution list or make copies

The Cases: Diabetes App Modules

Restricted - do not distribute beyond defined distribution list or make copies

The Results - Significant Improvement on Health and Claims Costs

• 100,000 people with type 2 went through the program

• 70% engagement

• -7.5kg weight loss (-7% mean loss)

• -16 mmol/mol (1.2%) HbA1c reduction

• 37% of people reduce the number of medications they take

• 60% of people on insulin eliminate medication

• 1 in 2 in type 2 diabetes remission

Restricted - do not distribute beyond defined distribution list or make copies

Health Cost Improvements

43% 16% 19% 21% 37%

AmputationsAdverse

OutcomesHeart FailureMicrovascular

ComplicationsCataracts

Reducing HBA1C by 1%

Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes. British Medical Journal 2000; 321: 405-412Impact of Glyceamic Control on Healthcare Resource Utilization and Costs of Type 2 Diabetes: American Health & Drug Benefits. 2013; 6(7): 382-392

Restricted - do not distribute beyond defined distribution list or make copies

Restricted - do not distribute beyond defined distribution list or make copies

Legal notice

©2017 Swiss Re. All rights reserved. You are not permitted to create any modifications or derivative works of this presentation or to use it for commercial or other public purposes without the prior written permission of Swiss Re.

The information and opinions contained in the presentation are provided as at the date of the presentation and are subject to change without notice. Although the information used was taken from reliable sources, Swiss Re does not accept any responsibility for the accuracy or comprehensiveness of the details given. All liability for the accuracy and completeness thereof or for any damage or loss resulting from the use of the information contained in this presentation is expressly excluded. Under no circumstances shall Swiss Re or its Group companies be liable for any financial or consequential loss relating to this presentation.